About the Feline Sarcoma Virus Session
Feline Sarcoma Virus (FeSV) is a retrovirus notorious for instigating sarcomas in cats, serving as a pivotal tool in cancer research. FeSV's knack for integrating its genetic material into the host's genome unleashes unchecked cell proliferation, culminating in tumor genesis. Investigation into FeSV has yielded profound insights into oncogenesis, tumor immunology, and therapeutic modalities. It serves as a potent model for unraveling the complexities of cancer biology, encompassing tumor initiation, progression, and metastasis. The exploration of FeSV's intricacies has catalyzed the innovation of groundbreaking cancer treatments and preventive vaccines, benefiting both feline and human cohorts. By deciphering the nuances of FeSV-induced oncogenesis, researchers strive to unveil overarching principles pivotal in combatting cancer across species domains.
Topics Covered in Feline Sarcoma Virus
Acute Transforming Virus
FeLV Recombination
Viral Oncogenes
Helper Virus Dependence
Multicentric Fibrosarcoma
Tyrosine Kinase Signaling
Related Scientific Sessions at CIOC 2027
Why Attend the Feline Sarcoma Virus Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Feline Sarcoma Virus work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Feline Sarcoma Virus research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Feline Sarcoma Virus track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Feline Sarcoma Virus Conference 2027 — FAQs
What is the Feline Sarcoma Virus track at CIOC 2027?
The Feline Sarcoma Virus track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Feline Sarcoma Virus. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Feline Sarcoma Virus sessions?
Cancer researchers and clinicians, educators and students with an interest in Feline Sarcoma Virus are all welcome — whether presenting or attending.
Can I present my research in the Feline Sarcoma Virus track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Feline Sarcoma Virus sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Feline Sarcoma Virus track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.